Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152231 | 12615223 | 1 | I | 20160720 | 20160802 | 20160802 | EXP | FR-MYLANLABS-2016M1031244 | MYLAN | JEANJEAN M-L, COUTURIER B, GREGOIRE C, GALBOIS A. AN UNUSUAL AND UNEXPECTED FINDING IN A CASE OF SELF-POISONING. DIG-LIVER-DIS 2016;48(7):824. | 0.00 | Y | 0.00000 | 20160802 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152231 | 12615223 | 1 | PS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 30 TABLETS | U | 77166 | TABLET | ||||||||
| 126152231 | 12615223 | 2 | SS | CYAMEMAZINE | CYAMEMAZINE | 1 | Oral | 30 TABLETS | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126152231 | 12615223 | 2 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126152231 | 12615223 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126152231 | 12615223 | Altered state of consciousness | |
| 126152231 | 12615223 | Intentional overdose | |
| 126152231 | 12615223 | Poisoning deliberate |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |